You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rectal Adenocarcinoma

Showing 1 - 25 of 5,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)

Recruiting
  • Rectal Adenocarcinoma
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Response After Neoadjuvant Treatment of Locally Advanced Rectal

Not yet recruiting
  • Rectal Cancer
  • PET-MRI
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Mar 15, 2023

Rectal Cancer Trial in Hangzhou (Envafolimab)

Recruiting
  • Rectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
May 4, 2023

Rectal Cancer Trial in Hangzhou (Envafolimab)

Not yet recruiting
  • Rectal Cancer
  • Envafolimab
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Mar 1, 2023

Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma Trial in United States (Trastuzumab,

Recruiting
  • Adenocarcinoma of the Rectum
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

Recruiting
  • Toripalimab
  • Radiation
  • Hangzhou, Zhejiang, China
    Zhengjiang Cancer Hospital
Dec 29, 2022

Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Kaliningrad (Right hemicolectomy, Left hemicolectomy, Sigmoid colon

Recruiting
  • Colorectal Cancer
  • +5 more
  • Right hemicolectomy
  • +6 more
  • Kaliningrad, Kaliningrad Region, Russian Federation
    Baltic Federal University
Sep 15, 2023

Rectal Cancer Patients Based on ctDNA-MRD Technology

Recruiting
  • Rectal Adenocarcinoma
  • +3 more
  • MRD detection
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Jul 31, 2023

Colon Cancer, Rectal Cancer, Colon Adenocarcinoma Trial in Seoul (Monofix)

Completed
  • Colon Cancer
  • +3 more
  • Monofix
  • Seoul, Gangnam, Korea, Republic of
    Samsung Medical Center
May 14, 2023

Rectum Adenocarcinoma Trial in Paris, Saint-Cloud (Biopsy)

Recruiting
  • Rectum Adenocarcinoma
  • Biopsy
  • Paris, Ile De France, France
  • +2 more
Mar 30, 2022

Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)

Active, not recruiting
  • Rectal Adenocarcinoma
  • Portland, Oregon
    Providence Cancer Center
Mar 22, 2022

Rectal Adenocarcinoma Trial in Chapel Hill (other, radiation, drug)

Withdrawn
  • Rectal Adenocarcinoma
  • Chemoradiation
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 2, 2021

Improve Organ Preserving Strategies in Rectal Cancer

Recruiting
  • Rectal Adenocarcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 30, 2022

Rectal Adenocarcinoma Trial in Milwaukee (Capecitabine, Initial Dose of Radiation before Dose Escalation, Cohort A: Dose

Recruiting
  • Rectal Adenocarcinoma
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jul 19, 2022

Rectal Adenocarcinoma, Rectum Tumor, Rectum Carcinoma Trial in Helsinki, Tampere, Turku (Oral Antibiotics, Placebo, Mechanical

Active, not recruiting
  • Rectal Adenocarcinoma
  • +7 more
  • Oral Antibiotics
  • +2 more
  • Helsinki, Finland
  • +2 more
Nov 16, 2022

Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma Trial in San Francisco (Dietary intervention via Text

Not yet recruiting
  • Colon Adenocarcinoma
  • +2 more
  • Dietary intervention via Text Messaging
  • +2 more
  • San Francisco, California
  • +1 more
Feb 17, 2023

Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR

Completed
  • Metastatic Colorectal Adenocarcinoma
    • (no location specified)
    Oct 9, 2023

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2

    Recruiting
    • Metastatic Colon Adenocarcinoma
    • +20 more
    • CXCR1/2 Inhibitor SX-682
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 17, 2022

    Rectal Adenocarcinoma Trial in Baltimore (FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}, Low dose fractionated

    Terminated
    Has Results
    • Rectal Adenocarcinoma
    • FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
    • Low dose fractionated radiation therapy (LDFRT)
    • Baltimore, Maryland
      Ummc Msgcc
    Oct 6, 2021

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

    Terminated
    • Metastatic Colon Adenocarcinoma
    • +27 more
    • San Francisco, California
    • +1 more
    Jan 5, 2023

    Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,

    Completed
    • Rectal Adenocarcinoma
    • +4 more
    • Quality-of-Life Assessment
    • +2 more
    • Scottsdale, Arizona
    • +1 more
    Jan 3, 2023

    Quality of Life and Utilities Following Surgical Treatment of

    Recruiting
    • Rectal Adenocarcinoma
    • +13 more
    • Quality-of-Life Assessment
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Washington (Atezolizumab, Bevacizumab)

    Not yet recruiting
    • Colon Adenocarcinoma
    • +6 more
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Jul 28, 2022

    Strategy for Rectal Cancer. Can we ProvideMore Precise and

    Active, not recruiting
    • Rectal Cancer
    • +2 more
      • Aalborg, Denmark
        Aalborg University Hospital
      Mar 1, 2022

      Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,

      Terminated
      • Rectal Mucinous Adenocarcinoma
      • +8 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 21, 2022